Worldwide Markets and Emerging Technologies for Point-of-Care Testing

Companies Covered

77 Elektronika Kft.
3M
A. Menarini Diagnostics
Abaxis Inc.
Abbott
Abbott Architect
Abbott Diagnostics
Abbott Laboratories Inc.
Abbott POC (fka i-STAT)
Abbott Point of Care
ABT GmbH
Access Diagnostic Tests UK Ltd
Accriva Diagnostics
Accumetrics Inc.
AccuTech
ACON Laboratories
Acro Biotech LLC
Adaltis Inc.
Adnavance Technologies
Advantage Diagnostics
Aerscher Diagnostics
AgaMatrix
Aggredyne
AiMedics Pty Ltd.
Akubio
Albertsons (unit of SUPERVALU)
Alere (fka Inverness Medical Innovations)
Alfa Scientific Designs
Alfa Wassermann S.p.A
AllMedicus
Alternecare Health Products
Amazon
American Biomedica Corporation
AmerisourceBergen Corporation
Amgen
Amira Medical
Amylin Pharmaceuticals
Andiatech
ANI Biotech Oy
Apex Biotechnology
Arax Co. Ltd.
Arkray
Arlington Scientific
Arriva
AstraZeneca PLC
Astute Medical
Atlas Link
Audit Diagnostics
Aventir Biotech
AVL List GmbH
AVL Medical
Awareness Technology
Axis-Shield plc
Azo Products
B. Braun Melsungen
Babystart
Ballard Medical (unit of Kimberley-Clark)
Bayer Corporation
Bayer Diabetes Care
Beckman Access
Beckman Coulter
Becton Dickinson
BeneCheck/General Life Biotechnology Co.
Bestgen Biotech
Binax
Bio/Data
BioHelix Corporation
BioMedica Diagnostics
Biomedical Diagnostics Institute National Centre for Sensor Research
Biomedix
Biomerica
bioMerieux
Bionime
Bio-Rad Laboratories
Biosafe Laboratories
Biosite Diagnostics
Biosurfit SA
Biotechnostix
BioTex
BODITECH MED
BodyTel
Boule Diagnostics
Brahms Diagnostica USA
Branan Medical
Calypte Biomedical
Cardinal Health
CardioGenics
CARE Diagnostica
Cepheid Inc.
Ceragem Medisys
CH Werfen/Werfen Life Group
Chek Diagnostics (fka PTS Diagnostics)
Chembio Diagnostic Systems
ChemTrak
Chiron (unit of Novartis)
Cholestech
Church & Dwight
Cigna
Claros Diagnostics
CLIA Waived
Clinical Data
Clinical Genomics
CLONDIAG Chip Technologies GmbH
CoaguSense
Cole Taylor
Concateno plc
Confirm Biosciences
Consult
Corgenix
Coris Bioconcept
Cozart Bioscience Ltd.
CTK Biotech
CVS Caremark
Daiichi Sankyo
Daktari Technologies
Danaher
DexCom
Diabetech
Diagnostic Technology Pty Ltd.
Diagnostic Test Group
Diametrics
Diesse Diagnostica
DNA Direct
Dr. Langer Medical
Drew Scientific
Drucker Diagnostics
Drug Free Enterprises/Express Diagnostics International
EarlyPregnancyTests.com
Echo Therapeutics (fka Sontra Medical)
Edwards Lifesciences
Edwards Medical Supply
EKF Diagnostics
Ekos
Eli Lilly and Company
ELITech Group
Embroytech Labs
Enigma Diagnostics Ltd.
Enterix (unit of Quest Diagnostics)
Epigenomics AG
Epistem
Epocal
EPS Biotechnology
Eumed Biotechnology
Eurolyser Diagnostica
Exact Sciences
F. Hoffmann-La Roche Ltd
Fiomi Diagnostics
First Check
Franklin Diagnostics
Fujirebio Inc.
GDS Technology (unit of Stanbio)
GE Healthcare
GE Medical Systems
GenBio (Innominate)
General Life Biotechnology
Genexo Sp. z o.o.
Gen-Probe
Genzyme
Germaine Laboratories
Germaine Labs
Geron Corporation
GlaxoSmithKline
GlucoLight
Glucostats System Ptd Ltd.
GluMetrics
GlySens
Great Basin Scientific
Grove Instruments
Guangzhou Wondfo Biotech
Haemonetics
Hainice Medical
HandyLab
Healthpia
Heidelberger Medical Marketing
Helena Laboratories, Inc.
Hema Diagnostic Systems
HemoCue AB
HemoSense
HemoSonics LLC
Hemosure/W.H.P.M.
Henry Schein
Hiedelberger Medical Marketing
Hitachi
Hologic
Home Access Health
Home Diagnostics
Home Health Testing
HomeDrugTestingKit.com
Honeywell International
Horiba Ltd.
HuBit
Human Diagnostics
Humasis
Hycor Biomedical (unit of Agilent Technologies)
IDEXX Laboratories
iHealth Labs/Andon Health
iLine Microsystems
Immunostics
Infectio Diagnostic (unit of BD/Geneohm)
Infopia Co. Ltd.
InLight Solutions
InLine Microsystems
Innotrac Diagnostics Oy (unit of Radiometer)
Innovative BioSystems
Inova LAB s.r.l.
Insight Pharmaceuticals
Instant Technologies/Accu-Stat Diagnostics
Instrumentation Laboratory
Insulet
Intec Products
Integrated Nano-Technologies
Integrity Applications
Intel Corporation
IntelliGender
International Immunodiagnostics
International Stem Cell
International Technidyne (Thoratec)
Invacare
Iquum
IRIS Diagnostics
IRIS International
Ischemia Technologies
i-sens
ISIS Pharmaceuticals
Itamar Medical
J. Mitra
Jant Pharmacal
JEI Daniel Biotech
Jhonghe City
Johnson & Johnson
Korea Telecom
Kyoto Daiichi Kagaku Co. (KDK) (unit of Arkray)
LabNOW
Labsystems Diagnostics Oy
Landmark Diagnostics
Lein Applied Diagnostics
LifeHealth
LifeScan
LifeSign/PBM
LighTouch Medical
Lobeck Medical
LRE Relais + Elektronik
Luminous Medical
Magellan Biosciences/ESA
Magellan Diagnostics
Magna BioSciences
Magnetic Diagnostics
Mainline Technology
Mallinckrodt Medical
Masimo
Matria
Maxwell Sensors
MaybeMOM
mBio Diagnostics (division of Precision Photonics)
McKesson
MDY Healthcare Plc (formerly Medisys)
Medarex
Medica
Medical Automation Systems, Inc.
Medi-Lab
Medimmune
Medimpex United
Medline
MedMira
Medonic (unit of Boule Diagnostics/Boule Medical AB)
Medtox Scientific Inc.
Medtronic Blood Management
Medtronic Cardiac Surgery
Medtronic Hemotec
Medtronic Inc.
Menarini
Menarini Diagnostics
Merck & Company
Meridian
Meridian Bioscience
MicroIslet
MicroPoint Bioscience
Mindray Medical International
Mitra
Mitsubishi Chemical
Mitsubishi Kagaku
Moore Medical
Nano Entek
Nano-Ditech
Nanogen
Nanomix
Nanosphere
New Horizons Diagnostics
Nipro Diagnostics
Noble Medical
Northrop Grumman
NOVA Biomedical
Nova Century
Novocell
Omega Pharmaceuticals
OPKO Health
Opti Medical
OptiScan Biomedical
OraSure Technologies Inc.
Oratel Diagnostics
Orgenics
OrSense
Ortho Clinical Diagnostics
Ortho Vitros ES
Ortho-Clinical Diagnostics
Osmetech
Oxoid (unit of Thermo Fisher Scientific)
Panasonic Shikoku Electronics
Paradigm Health
PATH (Program for Appropriate Technology in Health)
Permaxim
Pfizer
Phadia
Phamatech
Pharmanetics
Philips Healthcare
Polymedco
Polymer Technology Systems
Preventx
Princeton
Princeton BioMeditech Corporation
Procter & Gamble
Prodesse
PSS World Medical
QBC Diagnostics/The Drucker Company
Qualigen
Quest Diagnostics
Quidel, Inc.
Radiometer International A/S
Redwood Biotech (unit of Inverness Medical)
ReLIA Biotechnologies
ReLIA Diagnostic Systems
Remel (unit of Thermo Fisher Scientific)
ReNeuron Group
Response Biomedical
Rite-Aid
Roche
Roche Diagnostics (fka Boehringer Mannheim Diagnostics)
Rohto Pharmaceutical
Royal Philips Electronics
SA Scientific
Sacks Medical
Samsung
Sanitoets Closed Corp/Sallamander Concepts
Sanvita
Sanwa Kaguku Kenkyusho
Schering Plough
SD Biosensor
Sekisui
Select Diagnostics
SenDx Medical
Senseonics
Sensile Medical
Sensors for Medicine and Science
Separation Technology
Seradyn
Sichuan Maker Biotechnology
Siemens
Siemens Diagnostics (fka Dade Behring)
Silicon BioDevices
Siloam
Socrates Health Solutions
Sparton
Spectral Diagnostics Inc.
Spectral Medical, Inc.
Stanbio Laboratory
Stanbio/Alere
Standard Diagnostics
Stem Cells Inc.
Swiss Precision Diagnostics
Synova
Syntron
Sysmex
T2 Biosystems
Taidoc
Takeda Pharmaceutical
Target
Techno Medica Co. Ltd.
Teco Diagnostics
TEM International
Terumo
The Carlyle Group
The McDevitt Research Group
Thermo Biostar
Thermo Fisher Scientific Inc.
Thoratec
ThromboVision
Tianjin New Bay Bioresearch
TKNO
Tosoh
Tosoh AIA
Trinity Biotech
TwistDx
Tyson Bioresearch
U.S. Diagnostics
UCP Biosciences
Veralight
Visgeneer
Visual Pathways
Vital Diagnostics
Vivacta
VivoMedical
VolitionRx Ltd.
Walgreen Company
Walmart Stores
Wampole Laboratories
X-Bar Diagnostic Systems
YD Diagnostics
Yellow Springs Instruments, Inc.
YSI
Yu.Sys
Zetek

Table of Contents

EXECUTIVE SUMMARY

Exhibit ES-1: Worldwide POC In-Vitro Diagnostics Market, 2013-2019
Exhibit ES-2: Worldwide POC Test Volume Distribution by Site, 2013-2019
Exhibit ES-3: Worldwide POC Diagnostics Market Trend by Test Site, 2013-2019
Exhibit ES-4: Worldwide Hospital POC Testing Products Market by Segment, 2013-2019
Exhibit ES-5: Worldwide Home/Self-Testing Products Market, 2013-2019
Exhibit ES-6: Global Physician's Office Laboratory Market by Test Segment
Exhibit ES-7: Comparison of POC Market Segment Growth Rates, 2014-2019
Exhibit ES-8: 2014 POC IVD Suppliers' Sales and Market Share

1. MARKET OVERVIEW

1.1 Trends in the Global Clinical Diagnostics Market
1.2 Clinical Diagnostics Market and Technology Trends by Segment
1.2.1 Clinical Chemistry
1.2.2 Immunodiagnostics
1.2.3 Hematology and Coagulation
1.2.4 Microbiology
1.2.5 Molecular Diagnostics
1.3 Trends in Laboratory Restructuring and the Organization of Testing
1.4 Factors Driving the Adoption of Point-of-Care Testing Regulatory Trends Impacting the Use of Point-of-Care Testing
1.6 Cost and Reimbursement Issues in Point-of-Care Testing
1.7 Quality Control and Quality Assurance Issues in Point-of-Care Testing
1.8 Trends in Self-Monitoring, Disease Screening, Wellness Testing, Risk Assessment and Preventative Testing
1.9 Changes in the Site of Health Care Delivery

Exhibit 1.1: Global Medical Device and Diagnostics Market, 2013-2019
Exhibit 1.2: Trends in Population 65 and Older and Health Expenditures, Selected Countries
Exhibit 1.3: U.S. Surgical Procedure Volume by Site, 2013
Exhibit 1.4: Expansion of Clinical Lab Automation in the U.S.
Exhibit 1.5: Changes to the Clinical Laboratory Fee Schedule in the U.S., 2000-2014
Exhibit 1.6: Trends in the Site of Laboratory-Based Testing in the U.S., 2002-2014
Exhibit 1.7: Worldwide Clinical Diagnostics Market by Segment, 2013-2019
Exhibit 1.8: Worldwide Clinical Diagnostic Products Market by Region
Exhibit 1.9: Worldwide Clinical Chemistry Market, 2013-2019
Exhibit 1.10: 2014 Worldwide Immunoassay Reagent and Supply Market by Segment
Exhibit 1.11: Worldwide Hematology/Coagulation Testing Products Market, 2013-2019
Exhibit 1.12: Worldwide Microbiology Market by Segment
Exhibit 1.13: Worldwide Molecular Diagnostics Market by Application Segment, 2013-2019
Exhibit 1.14: Number of CLIA-Registered U.S. Clinical Laboratories by Type, 2000-2014
Exhibit 1.15: Key Factors Driving Adoption of POC Testing
Exhibit 1.16: Trends in CLIA-Waived Labs vs. Total Labs in the U.S., 2004-2014
Exhibit 1.17: Waived Analyte Tests Performed in Clinical Labs
Exhibit 1.18: Waived Analyte Tests Performed by Type of Lab
Exhibit 1.19: Segmentation of Healthcare Costs in the U.S.
Exhibit 1.20: Historical Trends in the Number of Hospitals, Hospital Beds, Hospital Admissions, and Average Hospital Stay
Exhibit 1.21: Trend in the Number of Retail Medical Clinics in the U.S.

2. HOSPITAL-BASED POINT-OF-CARE TESTING PRODUCTS

2.1 Hospital Diagnostic Testing Environment
2.2 Bedside Critical Care Testing Products Market
2.2.1 Trends in POC Critical Care Test Volume and Equipment Installed Base
2.2.2 Existing POC Critical Care Testing Products
2.2.3 New Technologies Under Development for POC Bedside Critical Care Testing
2.2.4 Bedside Critical Care Testing Market Analysis and Forecast
2.2.5 Bedside Critical Care Testing Product Suppliers' Sales and Market Shares
2.2.6 Drivers and Limiters of the Hospital POC Critical Care Testing Products Market
2.3 Hospital Bedside Hemostasis Testing Products Market
2.3.1 Trends in POC Hemostasis Test Volume and Equipment Installed Base
2.3.2 Existing POC Hemostasis Testing Products
2.3.3 New Products and Technologies Under Development for POC Hemostasis Testing
2.3.4 Hospital-Based POC Hemostasis Testing Market Analysis and Forecast
2.3.5 Hospital-Based POC Hemostasis Testing Product Suppliers' Sales and Market Shares
2.3.6 Drivers and Limiters of the Hospital POC Hemostasis Testing Products Market
2.4 Bedside/POC Drugs of Abuse Testing Products Market
2.4.1 Trends in Bedside/POC Drugs of Abuse Testing
2.4.2 Existing Bedside/POC Drugs of Abuse Testing Products
2.4.3 POC Drugs of Abuse Testing Market Analysis and Forecast
2.4.4 POC Drugs of Abuse Testing Product Suppliers' Sales and Market Shares
2.4.5 Drivers and Limiters of the Hospital POC Drugs of Abuse Testing Products Market
2.5 POC Cardiac Marker Testing Products Market Analysis
2.5.1 Trends in POC Cardiac Marker Testing
2.5.2 POC Cardiac Marker Products Under Development
2.5.3 POC Cardiac Marker Market Analysis and Forecast
2.5.4 POC Cardiac Marker Product Suppliers' Sales and Market Shares
2.5.5 Drivers and Limiters of the POC Cardiac Marker Testing Products Market
2.6 Other Bedside/POC Testing Products Markets
2.6.1 POC Infectious Disease Testing Products, Market Analysis and Suppliers
2.6.2 POC Products and Markets for Hemoglobin and Hematocrit Testing
2.6.3 Hospital and Institutional Bedside Whole Blood Glucose Monitoring Market
2.6.3.1 Products for Hospital/Institutional Bedside Whole Blood Glucose Monitoring
2.6.3.2 Hospital/Institutional Bedside Whole Blood Glucose Monitoring Market Analysis
2.6.3.3 Drivers and Limiters of the Hospital/Institutional Bedside Whole Blood Glucose Monitoring Products Market
2.6.3.4 Other Hospital Bedside POC Testing Products

Exhibit 2.1: Hospital Sites for Clinical Diagnostic Testing in the U.S.
Exhibit 2.2: Clinical Testing Site Distribution for Selected Countries
Exhibit 2.3: Trends in Global Hospital-Based POC In-Vitro Diagnostic Test Volume
Exhibit 2.4: Trends in Worldwide Hospital POC Test Volume by Analyte Segment
Exhibit 2.5: Trends in Emergency Room Visits and Number of Emergency Rooms in Community Hospitals in the U.S.
Exhibit 2.6: Distribution of Hospital-Based POC Test Volume by Site
Exhibit 2.7: Clinical Factors Driving Usage of Point-of-Care Testing
Exhibit 2.8: Trends in Worldwide POC Blood Gas/Electrolyte/Metabolite Test Volume and Instrument Installed Base
Exhibit 2.9: Existing POC Critical Care Testing Products
Exhibit 2.10: Development-Stage POC Critical Care Testing Products
Exhibit 2.11: Worldwide Market for Hospital POC Critical Care Testing Products
Exhibit 2.12: Worldwide Market for POC Single-Test Cartridge Critical Care Testing Products
Exhibit 2.13: Worldwide Market for POC Multi-Test Cartridge Critical Care Testing Products
Exhibit 2.14: Laboratory Versus POC Critical Care Testing Products Market
Exhibit 2.15: 2014 Worldwide Sales and Market Share for Leading Suppliers of POC Critical Care Testing Products
Exhibit 2.16: 2014 Worldwide Sales and Market Share for Leading Suppliers of POC Critical Care Testing Products by Region
Exhibit 2.17: Diseases and Procedures with Indications for Anti-coagulation Therapy
Exhibit 2.18: Trends in Diagnosis of Atrial Fibrillation in U.S. Hospital Patients, 1996-2006
Exhibit 2.19: Platelet Aggregation/Platelet Function Test Volume Trend in the U.S. Medicare Population, 2002-2013
Exhibit 2.20: Trends in Worldwide POC Hemostasis Test Volume and Instrument Installed Base
Exhibit 2.21: Existing POC Hemostasis Testing Products
Exhibit 2.22: Worldwide Market for Hospital POC Hemostasis Testing Products
Exhibit 2.23: Worldwide Market for Hospital POC Hemostasis Testing Products by Segment
Exhibit 2.24: Laboratory Versus Hospital-Based POC and Self-Test Hemostasis Products Market, 2013-2019
Exhibit 2.25: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemostasis Testing Products
Exhibit 2.26: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemostasis Testing Products by Region
Exhibit 2.27: CMS Decision Memorandum Observations
Exhibit 2.28: Number and Percentage of U.S. ED Visits Involving Illicit Drug Use, 2006 and 2011
Exhibit 2.29: Existing Hospital POC Drugs of Abuse Testing Products
Exhibit 2.30: Worldwide Market for POC Drugs-of-Abuse Testing Products (Hospital Segment)
Exhibit 2.31: Worldwide Market for Laboratory Versus POC Drugs-of-Abuse Testing Products (Hospital Segment)
Exhibit 2.32: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Drugs-of-Abuse Testing Products by Region
Exhibit 2.33: Analytical Characteristics of Cardiac Troponin I and T Assays for POC and Laboratory Use
Exhibit 2.34: Existing Hospital POC Cardiac Marker Testing Products
Exhibit 2.35: New POC Cardiac Marker Testing Products Under Development
Exhibit 2.36: Worldwide Market for POC Cardiac Marker Products
Exhibit 2.37: Worldwide Market for Laboratory Versus POC Cardiac Marker Products
Exhibit 2.38: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Cardiac Marker Products by Region
Exhibit 2.39: Existing Hospital POC Infectious Disease Testing Products
Exhibit 2.40: Worldwide Market for Hospital POC Infectious Disease Testing Products
Exhibit 2.41: Worldwide Market for Laboratory Versus Hospital POC Infectious Disease Testing Products
Exhibit 2.42: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Infectious Disease Testing Products by Region
Exhibit 2.43: Worldwide Market for Hospital POC Hemoglobin and Hematocrit Testing Products
Exhibit 2.44: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemoglobin and Hematocrit Testing Products by Region
Exhibit 2.45: Existing Hospital POC Whole Blood Glucose Monitoring Products
Exhibit 2.46: Worldwide Market for Hospital POC Whole Blood Glucose Products by Segment
Exhibit 2.47: Total Worldwide Market for Hospital POC Whole Blood Glucose Testing Products
Exhibit 2.48: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Whole Blood Glucose Testing Products by Region

CHAPTER 3: HOME AND SELF-TESTING PRODUCTS

3.1 Whole Blood Glucose Self-Testing Products Market
3.1.1 Existing Whole Blood Glucose Self-Testing Products
3.1.2 Development-Stage Whole Blood Glucose Self-Testing Products
3.1.2.1 Integrated Glucose Testing Devices
3.1.2.2 Implantable Glucose Monitors
3.1.2.3 Non-Invasive Glucose Monitoring
3.1.3 Whole Blood Glucose Self-Testing Products Market Analysis and Forecast
3.1.4 Whole Blood Glucose Self-Testing Product Suppliers' Sales and Market Shares
3.1.5 Drivers and Limiters of the Whole Blood Glucose Self-Testing Products Market
3.2 OTC Pregnancy and Fertility Testing Products Market
3.2.1 Trends in Home Pregnancy and Fertility Testing
3.2.2 Existing Products for Home Pregnancy and Fertility Testing
3.2.3 New Products Under Development for Home Pregnancy and Fertility Testing
3.2.4 OTC Pregnancy and Fertility Testing Products Market Analysis and Forecast
3.2.5 OTC Pregnancy and Fertility Testing Product Suppliers' Sales and Market Shares
3.2.6 Drivers and Limiters of the OTC Pregnancy and Fertility Testing Products Market
3.3 Markets for Other Home and Self-Testing Products
3.3.1 Cholesterol Self-Testing
3.3.2 Fecal Occult Blood Testing
3.3.3 Home Drugs of Abuse Testing
3.3.4 Coagulation Self-Testing
3.3.5 Infectious Disease Self-Testing
3.3.6 Home Heart Failure Monitoring

Exhibit 3.1: Global Diabetes Prevalence Trends According to the World Health Organization and the International Diabetes Federation
Exhibit 3.2: Frequency of Blood Glucose Testing by Diabetics in the U.S.
Exhibit 3.3: Feature Comparison for Leading Brands and Models of Whole Blood Glucose Self-Testing Products
Exhibit 3.4: Other Suppliers of Glucose Self-Testing Products
Exhibit 3.5: Development-Stage Noninvasive/Minimally Invasive Glucose Monitoring Devices
Exhibit 3.6: Worldwide Market for Whole Blood Glucose Self-Testing Products
Exhibit 3.7: Worldwide Market for Whole Blood Glucose Test Strips, Self-Testing Segment
Exhibit 3.8: Worldwide Market for Lancets Used in Whole Blood Glucose Self-Testing
Exhibit 3.9: Worldwide Market for Whole Blood Glucose Self-Testing Products by Region, 2013-2019
Exhibit 3.10: 2014 Worldwide Sales and Market Shares for Leading Suppliers of Whole Blood Glucose Self-Testing Products
Exhibit 3.11: Home Pregnancy and Fertility Tests
Exhibit 3.12: Worldwide Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.13: Worldwide Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.14: Worldwide Market for OTC Fertility Testing Products, 2013-2019
Exhibit 3.15: U.S. Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.16: U.S. Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.17: U.S. Market for OTC Fertility Testing Products, 2014-2019
Exhibit 3.18: European Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.19: European Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.20: European Market for OTC Fertility Testing Products, 2013-2019
Exhibit 3.21: Japan/ROW Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.22: Japan/ROW Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.23: Japan/ROW Market for OTC Fertility Testing Products, 2013-2019
Exhibit 3.24: Worldwide Sales and Market Share for the Leading Suppliers of OTC Pregnancy and Fertility Testing Products, 2014
Exhibit 3.25: Worldwide Market for OTC Blood Lipid Testing Products, 2013-2019
Exhibit 3.26: Worldwide Sales and Market Share for the Leading Suppliers of OTC Blood Lipid Testing Products, 2014
Exhibit 3.27: Fecal Occult Blood Testing Products Available in the Global Market
Exhibit 3.28: Worldwide Market for Home Drugs of Abuse Testing Products, 2013-2019
Exhibit 3.29: Worldwide Sales and Market Share for the Leading Suppliers of Home Drugs of Abuse Testing Products, 2014
Exhibit 3.30: INR Self-Testing Products Available in the Global Market
Exhibit 3.31: Worldwide Market for PT/INR Self-Testing Products, 2013-2019
Exhibit 3.32: Worldwide Sales and Market Share for the Leading Suppliers of PT/INR Self-Testing Products, 2014

CHAPTER 4: PHYSICIAN'S OFFICE AND OTHER ALTERNATE SITE TESTING PRODUCTS

4.1 Types of Testing Performed in Physician Offices and Other Alternate Sites
4.2 Existing Physician's Office Laboratory Products
4.3 New POL Products Under Development
4.4 Physician's Office Laboratory Market Analysis
4.5 POL Product Suppliers' Sales and Market Shares
4.6 Drivers and Limiters of the Worldwide POL Products Market
4.7 Other Alternate Site Testing Products and Markets

Exhibit 4.1: Trends in the Number of CLIA-Registered Physician's Office and Other Selected Alternate Site Labs in the U.S.
Exhibit 4.2: Health Care Financing Administration, Center for Laboratories, CLIA Statistics for POLs as of November 2014 (POLs by Certificate Type)
Exhibit 4.3: Tests Ordered by Office-Based Physicians in the U.S., 2000-2006
Exhibit 4.4: Physician's Office Laboratory Products
Exhibit 4.5: New Products Under Development for the POL Market
Exhibit 4.6: Worldwide Market for Physician's Office Laboratory Testing Products, 2013-2019
Exhibit 4.7: Worldwide Market for Physician's Office Laboratory Testing Products by Segment, 2013-2019
Exhibit 4.8: Worldwide Sales and Market Share for the Leading Suppliers of POL Chemistry Products, 2014
Exhibit 4.9: Worldwide Sales and Market Share for the Leading Suppliers of POL Immunodiagnostic Products, 2014
Exhibit 4.10: Worldwide Sales and Market Share for the Leading Suppliers of POL Hematology Products, 2014
Exhibit 4.11: Worldwide Sales and Market Share for the Leading Suppliers of POL Rapid Test Kits, 2014
Exhibit 4.12: Worldwide Sales and Market Share for the Leading Suppliers of POL Urinalysis Products, 2014
Exhibit 4.13: Worldwide Sales and Market Share for the Leading Suppliers of POL Allergy Testing Products, 2014
Exhibit 4.14: Worldwide Sales and Market Share for the Leading Suppliers of POL Whole Blood Glucose Testing Products, 2014
Exhibit 4.15: Worldwide Sales and Market Share for the Leading Suppliers of POL Whole Blood Hemoglobin Testing Products, 2014
Exhibit 4.16: Worldwide Sales and Market Share for the Leading Suppliers of POL Glycated Hemoglobin Testing Products, 2014
Exhibit 4.17: Worldwide Sales and Market Share for the Leading Suppliers of POL Coagulation Testing Products, 2014
Exhibit 4.18: Combined Worldwide Sales and Market Shares of Leading Suppliers of Physician's Office Laboratory Products, 2014

CHAPTER 5: COMPETITOR ASSESSMENT

5.1 Overview of Companies in the Global POC Diagnostics Market
5.2 Mergers and Partnerships to Improve Competitive Position
5.3 Marketing and Distribution Strategies for the Global POC Diagnostics Market

Exhibit 5.1: Overview of Leading Competitors in the POC Diagnostics Market
Exhibit 5.2: Mergers, Acquisitions, and Partnerships Impacting the POC Diagnostics Market

CHAPTER 6: COMPANY PROFILES

6.1 Abaxis
6.2 Abbott Laboratories
6.3 Accriva Diagnostics
6.4 Alere
6.5 Alfa Wassermann
6.6 Arkray
6.7 Bayer Diabetes Care
6.8 Danaher
6.8.1 Beckman Coulter
6.8.2 Hemocue
6.8.3 Radiometer
6.9 Dexcom
6.10 ELITech Group
6.11 Helena Laboratories
6.12 Instrumentation Laboratory
6.13 Menarini Diagnostics
6.14 Nipro Diagnostics
6.15 NOVA Biomedical
6.16 OraSure Technologies
6.17 Ortho Clinical Diagnostics
6.18 Phamatech
6.19 Princeton BioMeditech
6.20 Quidel
6.21 Response Biomedical
6.22 Roche Diagnostics
6.23 Siemens Diagnostics
6.24 Trinity Biotech

APPENDIX - COMPANY LISTING

REFERENCES

COMPANY DIRECTORY